Kaposi Sarcoma Treatment Market to Perceive Substantial Growth During 2017–2022

Kaposi sarcoma is a malignant tumor disease majorly associated with skin, mucous membranes, lymph nodes, and other organs. Kaposi sarcoma causes lesions to grow in the skin, in the mucous membranes lining the mouth, nose, and throat, lymph nodes, and other organs. Human herpesvirus-8 (HHV-8) is majorly found in the lesion of all patients suffering from Kaposi sarcoma. However, patients with weakened immune systems by Acquired Immune Deficiency Syndrome (AIDS) disease or drugs prescribed post organ transplantation surgery are highly susceptible to HHV-8: a heterovirus, which contributes to the development of Kaposi sarcoma. Organ transplant patients are prescribed immunosuppressive agents to prevent their body from rejecting the graft, which increases their susceptibility towards Kaposi sarcoma associated herpesvirus (KSHV) infection. The long-term use of these agents increases the rate of risk of these patients by over 100 times as compared to the general population.

Get The Holistic SAMPLE With Research Methodology: https://www.coherentmarketinsights.com/insight/request-sample/1671

Kaposi Sarcoma Treatment Market Drivers

Increasing number of patients undergoing organ transplant procedures is the leading cause for growth of the Kaposi sarcoma treatment market, as patients undergoing organ transplants are highly susceptible to this cancer. For instance, according to the National Kidney Foundation (NKF), in 2014, 17,107 kidney transplants took place in the U.S. Among which, 11,570 came from deceased donors and 5,537 came from living donors. Furthermore, increasing incidence of HIV/AIDS-associated Kaposi sarcoma is one of the major factors driving the adoption of Highly Active Antiretroviral Therapy (HAART) therapy, which subsequently drives growth of the Kaposi sarcoma treatment market. For instance, according to the American Cancer Society (ACS), February 2016 data findings, around 1 in 200 transplant patients in the U.S. suffer from Kaposi sarcoma. In the U.S., Kaposi sarcoma is much more common among men than women, and is rarely observed among children. Additionally, according to the same source, it is more common among African Americans than in whites in the U.S in 2016.

Click To Continue Reading On Kaposi Sarcoma Treatment Market

You may be interested

Cladding Systems Market Shows Expected Trend to Guide from 2018-2026 with Growth Analysis
Business
Business

Cladding Systems Market Shows Expected Trend to Guide from 2018-2026 with Growth Analysis

Mohit Joshi - August 20, 2018

Cladding Systems Market report 2018-2026 focuses on the major drivers and restraints for the key players. These research report also provides granular analysis of the market share,…

Guar Gum Market Applications, Types and Market Analysis to 2026
Chemicals and Polymer Science
Chemicals and Polymer Science

Guar Gum Market Applications, Types and Market Analysis to 2026

Alex Mathew - August 20, 2018

Guar Gum Market report 2018-2026 focuses on the major drivers and restraints for the key players. These research report also provides granular analysis of the market share,…

Blister Packaging Market Trends Estimates High Demand by 2026
Business
Business

Blister Packaging Market Trends Estimates High Demand by 2026

Mohit Joshi - August 20, 2018

Blister Packaging Market report 2018-2026 focuses on the major drivers and restraints for the key players. These research report also provides granular analysis of the market share,…

Most from this category